Showing results (31-40 of 44) with videos related to

Sort By:
Pageof 5
Arthritis and Rheumatism|October 11, 2001
Two-year, blinded, randomized, controlled trial of treatment of active rheumatoid arthritis with leflunomide compared with methotrexate. Utilization of Leflunomide in the Treatment of Rheumatoid Arthritis Trial Investigator GroupS Cohen, G W Cannon, M Schiff, et al.
Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual International Conference|October 25, 2017
A hybrid, low-cost tissue-like epidural needle insertion simulatorB Esterer, S Gabauer, R Pichler, et al.
Clinical Rheumatology|March 1, 1984
Auranofin, gold sodium thiomalate, and placebo in the treatment of rheumatoid arthritis. Cooperative systematic studies of rheumatic diseasesH J Williams, J R Ward, M J Egger, et al.
The Journal of Rheumatology|February 11, 1999
Randomized clinical trials and longitudinal observational studies in systemic lupus erythematosus: consensus on a preliminary core set of outcome domainsJ S Smolen, V Strand, M Cardiel, et al.
Archives of Internal Medicine|November 26, 1999
Treatment of active rheumatoid arthritis with leflunomide compared with placebo and methotrexate. Leflunomide Rheumatoid Arthritis Investigators GroupV Strand, S Cohen, M Schiff, et al.
Arthritis and Rheumatism|March 4, 1998
Treatment of rheumatoid arthritis with oral type II collagen. Results of a multicenter, double-blind, placebo-controlled trialM L Barnett, J M Kremer, E W St Clair, et al.
Arthritis and Rheumatism|April 13, 2004
Sustained improvement over two years in physical function, structural damage, and signs and symptoms among patients with rheumatoid arthritis treated with infliximab and methotrexateR N Maini, F C Breedveld, J R Kalden, et al.
Bone Marrow Transplantation|November 2, 2004
Consensus statement concerning cardiotoxicity occurring during haematopoietic stem cell transplantation in the treatment of autoimmune diseases, with special reference to systemic sclerosis and multiple sclerosisR Saccardi, A Tyndall, G Coghlan, et al.
Science Advances|June 18, 2025
Hypophagia and body weight loss by tirzepatide are accompanied by fewer GI adverse events compared to semaglutide in preclinical modelsTito Borner, Allison M Pataro, Sarah A Doebley, et al.
Arthritis and Rheumatism|December 14, 2004
Digital ulcers in systemic sclerosis: prevention by treatment with bosentan, an oral endothelin receptor antagonistJ H Korn, M Mayes, M Matucci Cerinic, et al.
Pageof 5